Skip to main content

Table 4 Hazard ratios and 95% confidence intervals for all-cause mortality in quintiles of baseline SUA/Cr by sex

From: Serum uric acid to creatinine ratio is a useful predictor of all-cause mortality among hypertensive patients

Baseline characteristic

Quintile of baseline SUA/Cr

P for trend

Firsta (n = 406)

Secondb (n = 402)

Thirdc (n = 403)

Fourthd (n = 406)

Fifthe (n = 400)

Male (n = 916)

     

0.020

 Prevalence

89 (44.1)

57 (29.5)

65 (39.2)

64 (33.0)

52 (32.3)

 

 Nonadjusted

1.74 (1.24–2.42)

1.00

1.23 (0.86–1.75)

1.04 (0.73–1.48)

0.88 (0.61–1.28)

< 0.001

 Age and eGFR-adjusted

1.35 (0.97–1.89)

1.00

1.33 (0.93–1.91)

1.43 (0.99–2.06)

1.60 (1.07–2.38)

0.186

 Multivariate-adjustedf

1.28 (0.91–1.80)

1.00

1.38 (0.95–1.98)

1.37 (0.94–2.00)

1.57 (1.03–2.40)

0.277

Female (n = 1,001)

     

0.836

 Prevalence

64 (31.7)

55 (26.3)

67 (28.3)

58 (27.4)

68 (28.5)

 

 Nonadjusted

1.08 (0.75–1.57)

1.00

0.90 (0.63–1.29)

0.91 (0.63–1.31)

1.04 (0.73–1.49)

0.786

 Age and eGFR-adjusted

0.93 (0.65–1.33)

1.00

0.97 (0.68–1.39)

1.30 (0.89–1.89)

1.41 (0.98–2.05)

0.099

 Multivariate-adjustedf

0.92 (0.64–1.33)

1.00

1.04 (0.72–1.50)

1.56 (1.06–2.30)

1.59 (1.06–2.38)

0.016

Total (n = 2,017)

     

0.030

 Prevalence

153 (37.7)

112 (27.9)

132 (32.8)

122 (30.0)

120 (30.0)

 

 Nonadjusted

1.38 (1.08–1.76)

1.00

1.02 (0.80–1.32)

0.97 (0.75–1.25)

0.96 (0.74–1.24)

0.010

 Age, sex, and eGFR-adjusted

1.13 (0.88–1.44)

1.00

1.15 (0.89–1.48)

1.37 (1.06–1.79)

1.54 (1.17–2.02)

0.018

 Multivariate-adjustedf

1.09 (0.85–1.39)

1.00

1.19 (0.92–1.54)

1.42 (1.09–1.86)

1.61 (1.21–2.14)

0.010

  1. Data are presented as number (%) or hazard ratio (95% confidence interval)
  2. SUA/Cr Serum uric acid to creatinine, eGFR Estimated glomerular filtration rate
  3. a202 Male and 204 female participants, < 5.89
  4. b193 Male and 209 female participants, 5.89–6.99
  5. c166 Male and 237 female participants, 7.00–7.87
  6. d194 Male and 212 female participants, 7.88–9.00
  7. e161 Male and 239 female participants, ≥ 9.01
  8. fAdjusted for baseline of all confounding factors in Table 2